000 | 00953 a2200265 4500 | ||
---|---|---|---|
005 | 20250513144344.0 | ||
264 | 0 | _c19980910 | |
008 | 199809s 0 0 eng d | ||
022 | _a0269-9370 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHavlir, D V | |
245 | 0 | 0 |
_aNew antiretrovirals and new combinations. _h[electronic resource] |
260 |
_bAIDS (London, England) _c1998 |
||
300 |
_aS165-74 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aHIV _xdrug effects |
650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
650 | 0 | 4 |
_aHIV Protease Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
700 | 1 | _aLange, J M | |
773 | 0 |
_tAIDS (London, England) _gvol. 12 Suppl A _gp. S165-74 |
|
999 |
_c9599326 _d9599326 |